Development of glycopolymers for the therapy of viral infections - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

102.884.1 IP-LS

Project title

Development of glycopolymers for the therapy of viral infections

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	Development of glycopolymers for the therapy of viral infections
Short description (English)	Development of glycopolymers for the therapy of viral infections
Abstract (German)	In response to the COVID-19 pandemic we developed a novel therapeutic approach to tackle viral infections. We demonstrated that our glycopolymers successfully inhibit viral protein attachment of a variety of unrelated viral pathogens and more specifically inhibit infection of SARS-CoV-2 in vitro.
Abstract (English)	In response to the COVID-19 pandemic we developed a novel therapeutic approach to tackle viral infections. We demonstrated that our glycopolymers successfully inhibit viral protein attachment of a variety of unrelated viral pathogens and more specifically inhibit infection of SARS-CoV-2 in vitro.